We previously demonstrated that CALNUC, a Ca2+-binding protein with two EF-hands, is the major Ca2+-binding protein in the Golgi by 45Ca2+ overlay (Lin, P., H. Le-Niculescu, R. Hofmeister, J.M. McCaffery, M. Jin, H. Henneman, T. McQuistan, L. De Vries, and M. Farquhar. 1998. J. Cell Biol. 141:1515–1527). In this study we investigated CALNUC's properties and the Golgi Ca2+ storage pool in vivo. CALNUC was found to be a highly abundant Golgi protein (3.8 μg CALNUC/mg Golgi protein, 2.5 × 105 CALNUC molecules/NRK cell) and to have a single high affinity, low capacity Ca2+-binding site (Kd = 6.6 μM, binding capacity = 1.1 μmol Ca2+/μmol CALNUC). 45Ca2+ storage was increased by 2.5- and 3-fold, respectively, in HeLa cells transiently overexpressing CALNUC-GFP and in EcR-CHO cells stably overexpressing CALNUC. Deletion of the first EF-hand α helix from CALNUC completely abolished its Ca2+-binding capability. CALNUC was correctly targeted to the Golgi in transfected cells as it colocalized and cosedimented with the Golgi marker, α-mannosidase II (Man II). Approximately 70% of the 45Ca2+ taken up by HeLa and CHO cells overexpressing CALNUC was released by treatment with thapsigargin, a sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) (Ca2+ pump) blocker. Stimulation of transfected cells with the agonist ATP or IP3 alone (permeabilized cells) also resulted in a significant increase in Ca2+ release from Golgi stores. By immunofluorescence, the IP3 receptor type 1 (IP3R-1) was distributed over the endoplasmic reticulum and codistributed with CALNUC in the Golgi. These results provide direct evidence that CALNUC binds Ca2+ in vivo and together with SERCA and IP3R is involved in establishment of the agonist-mobilizable Golgi Ca2+ store.
Skip Nav Destination
Article navigation
19 April 1999
Article|
April 19 1999
Overexpression of CALNUC (Nucleobindin) Increases Agonist and Thapsigargin Releasable Ca2+ Storage in the Golgi
Ping Lin,
Ping Lin
*Division of Cellular and Molecular Medicine, ‖Department of Pathology, ‡Department of Pharmacology, and §Howard Hughes Medical Institute, University of California San Diego, La Jolla, California 92093-0651
Search for other works by this author on:
Yong Yao,
Yong Yao
*Division of Cellular and Molecular Medicine, ‖Department of Pathology, ‡Department of Pharmacology, and §Howard Hughes Medical Institute, University of California San Diego, La Jolla, California 92093-0651
Search for other works by this author on:
Robert Hofmeister,
Robert Hofmeister
*Division of Cellular and Molecular Medicine, ‖Department of Pathology, ‡Department of Pharmacology, and §Howard Hughes Medical Institute, University of California San Diego, La Jolla, California 92093-0651
Search for other works by this author on:
Roger Y. Tsien,
Roger Y. Tsien
*Division of Cellular and Molecular Medicine, ‖Department of Pathology, ‡Department of Pharmacology, and §Howard Hughes Medical Institute, University of California San Diego, La Jolla, California 92093-0651
Search for other works by this author on:
Marilyn Gist Farquhar
Marilyn Gist Farquhar
*Division of Cellular and Molecular Medicine, ‖Department of Pathology, ‡Department of Pharmacology, and §Howard Hughes Medical Institute, University of California San Diego, La Jolla, California 92093-0651
Search for other works by this author on:
Ping Lin
*Division of Cellular and Molecular Medicine, ‖Department of Pathology, ‡Department of Pharmacology, and §Howard Hughes Medical Institute, University of California San Diego, La Jolla, California 92093-0651
Yong Yao
*Division of Cellular and Molecular Medicine, ‖Department of Pathology, ‡Department of Pharmacology, and §Howard Hughes Medical Institute, University of California San Diego, La Jolla, California 92093-0651
Robert Hofmeister
*Division of Cellular and Molecular Medicine, ‖Department of Pathology, ‡Department of Pharmacology, and §Howard Hughes Medical Institute, University of California San Diego, La Jolla, California 92093-0651
Roger Y. Tsien
*Division of Cellular and Molecular Medicine, ‖Department of Pathology, ‡Department of Pharmacology, and §Howard Hughes Medical Institute, University of California San Diego, La Jolla, California 92093-0651
Marilyn Gist Farquhar
*Division of Cellular and Molecular Medicine, ‖Department of Pathology, ‡Department of Pharmacology, and §Howard Hughes Medical Institute, University of California San Diego, La Jolla, California 92093-0651
Address correspondence to Marilyn G. Farquhar, Ph.D., Division of Cellular and Molecular Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0651. Tel.: (619) 534-7711. Fax: (619) 534-8549. E-mail: [email protected]
Received:
October 15 1998
Revision Received:
March 17 1999
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1999
J Cell Biol (1999) 145 (2): 279–289.
Article history
Received:
October 15 1998
Revision Received:
March 17 1999
Citation
Ping Lin, Yong Yao, Robert Hofmeister, Roger Y. Tsien, Marilyn Gist Farquhar; Overexpression of CALNUC (Nucleobindin) Increases Agonist and Thapsigargin Releasable Ca2+ Storage in the Golgi . J Cell Biol 19 April 1999; 145 (2): 279–289. doi: https://doi.org/10.1083/jcb.145.2.279
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement